Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse events

por Olie, R. H., van der Meijden, P. E. J., Vries, M. J. A., Veenstra, L., van ‘t Hof, A. W. J., ten Berg, J. M., Henskens, Y. M. C., ten Cate, H.
Publicado 2021

Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy

por de Breet, C. P. D. M., Zwaveling, S., Vries, M. J. A., van Oerle, R. G., Henskens, Y. M. C., van't Hof, A. W. J., van der Meijden, P. E. J., Veenstra, L., ten Cate, H., Olie, R. H.
Publicado 2021

PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION.

por Monard, Amaury, Heubel-Moenen, Fs.C.J.I., Castoldi, Elisabetta, De Simone, Ilaria, van der Meijden, P.E.J., Wichapong, Kanin, van Doorn, W.P.T.M., Spada, Stefano, Hellenbrand, D.L.S., Stork, A.D.M., Cate, Hugo Ten, Beckers, E.A.M., Henskens, Y.M.C.
Publicado 2023